Impact of age, tumor characteristics, and treatment on local control and disease outcome in early stage breat cancer : an EORTC translational research project

However, the outcome that one course of chemotherapy as a sole systemic therapy is able to induce a modest, but significant increase in overall survival and better locoregional

Patients who were planned for mastectomy but underwent breast- conserving therapy because of down- staging of the tumor did worse in terms of overall survival (HR, 2.53; 95% CI, 1.02

Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy.. Chollet P, Amat S,

Elkhuizen PH, van de Vijver MJ, Hermans J, Zonderland HM, van de Velde CJH, Leer JW (1998) Local recurrence after breast-conserving therapy for invasive breast cancer: high incidence

most recent follow-up of the Early Breast Cancer Trialists’ Collaborative Group (EBCTCG 2000 update) demonstrated a significant overall survival difference of 6.0% in favour

Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast

To test whether the observed prognostic impact of young would remain significant when other tumor characteristics are taken into account, we first performed univariate analyses

Randomized adjuvant trial of tamoxifen and goserelin versus cyclophosphamide, methotrexate, and fluorouracil: evidence for the superiority of treatment with endocrine blockade